Prognosis and management of acute myeloid leukemia in patients with Down syndrome
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognosis and management of acute myeloid leukemia in patients with Down syndrome
Authors
Keywords
-
Journal
Expert Review of Hematology
Volume 7, Issue 6, Pages 831-840
Publisher
Informa UK Limited
Online
2014-09-18
DOI
10.1586/17474086.2014.959923
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Outcome of Transplantation for Acute Myelogenous Leukemia in Children with Down Syndrome
- (2013) Johann K. Hitzler et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Exome sequencing identifies putative drivers of progression of transient myeloproliferative disorder to AMKL in infants with Down syndrome
- (2013) S. I. Nikolaev et al. BLOOD
- Development of acute megakaryoblastic leukemia in Down syndrome is associated with sequential epigenetic changes
- (2013) S. Malinge et al. BLOOD
- GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia
- (2013) I. Roberts et al. BLOOD
- Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international study
- (2013) M. Blink et al. HAEMATOLOGICA
- Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas
- (2013) Jonathan W. Friedberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy
- (2013) M V Stankov et al. LEUKEMIA
- GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia
- (2013) A Maroz et al. LEUKEMIA
- Inhibition of Wee1 Sensitizes Cancer Cells to Antimetabolite Chemotherapeutics In Vitro and In Vivo, Independent of p53 Functionality
- (2013) A. A. Van Linden et al. MOLECULAR CANCER THERAPEUTICS
- The landscape of somatic mutations in Down syndrome–related myeloid disorders
- (2013) Kenichi Yoshida et al. NATURE GENETICS
- Reduced intensity conditioning in allogeneic stem cell transplantation for AML with Down syndrome
- (2013) Hideki Muramatsu et al. PEDIATRIC BLOOD & CANCER
- Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
- (2012) U. Creutzig et al. BLOOD
- RNAi screening of the kinome with cytarabine in leukemias
- (2012) R. Tibes et al. BLOOD
- Clinical characteristics and outcome of refractory/relapsed myeloid leukemia in children with Down syndrome
- (2012) T. Taga et al. BLOOD
- How I treat pediatric acute myeloid leukemia
- (2012) J. E. Rubnitz BLOOD
- Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971
- (2012) April D. Sorrell et al. CANCER
- Identification of Regulators of Polyploidization Presents Therapeutic Targets for Treatment of AMKL
- (2012) Qiang Wen et al. CELL
- Phase I Pharmacokinetic/Pharmacodynamic Study of MLN8237, an Investigational, Oral, Selective Aurora A Kinase Inhibitor, in Patients with Advanced Solid Tumors
- (2012) A. Cervantes et al. CLINICAL CANCER RESEARCH
- High Risk of Symptomatic Cardiac Events in Childhood Cancer Survivors
- (2012) Helena J. van der Pal et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia
- (2012) C C Porter et al. LEUKEMIA
- Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children’s Oncology Group Study POG 9421
- (2012) M M O'Brien et al. LEUKEMIA
- A Unique Role of GATA1s in Down Syndrome Acute Megakaryocytic Leukemia Biology and Therapy
- (2011) Ana C. Xavier et al. PLoS One
- Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis
- (2010) J.-H. Klusmann et al. GENES & DEVELOPMENT
- miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia
- (2010) J.-H. Klusmann et al. GENES & DEVELOPMENT
- Mosaic Down syndrome-associated acute myeloid leukemia does not require high-dose cytarabine treatment for induction and consolidation therapy
- (2010) Kazuko Kudo et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Prognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients With Acute Myeloid Leukemia Treated Uniformly According to Trial AML-BFM 98
- (2010) Christine von Neuhoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
- (2010) Jeffrey E Rubnitz et al. LANCET ONCOLOGY
- Myeloid leukaemia in children with down syndrome: Report of the registry-based French experience between 1990 and 2003
- (2010) Julie Tandonnet et al. PEDIATRIC BLOOD & CANCER
- Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome
- (2009) S. Malinge et al. BLOOD
- Down Syndrome and Malignancies: A Unique Clinical Relationship
- (2009) Ana C. Xavier et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents
- (2009) H. Hirai et al. MOLECULAR CANCER THERAPEUTICS
- Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations
- (2008) O. Tunstall-Pedoe et al. BLOOD
- Trisomy 21 enhances human fetal erythro-megakaryocytic development
- (2008) S. T. Chou et al. BLOOD
- Treatment and prognostic impact of transient leukemia in neonates with Down syndrome
- (2008) J.-H. Klusmann et al. BLOOD
- Acute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndrome
- (2008) Asahito Hama et al. BRITISH JOURNAL OF HAEMATOLOGY
- Cardiomyopathy in Children With Down Syndrome Treated for Acute Myeloid Leukemia: A Report From the Children's Oncology Group Study POG 9421
- (2008) Maureen M. O'Brien et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now